Period Ending | Dec 31, 2011 | Sep 30, 2011 | Jun 30, 2011 | Mar 31, 2011 |
---|
Total Revenue
|
19,555,000
|
17,727,000
|
16,543,000
|
14,910,000
| Cost of Revenue | 16,227,000 | 14,325,000 | 13,138,000 | 12,049,000 | |
Gross Profit
|
3,200,000
|
3,402,000
|
3,405,000
|
2,861,000
| |
|
Operating Expenses |
|
Research Development | 913,000 | 901,000 | 1,047,000 | 1,057,000 |
|
Selling General and Administrative | 788,000 | 756,000 | 782,000 | 804,000 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
1,597,000
|
1,713,000
|
1,534,000
|
1,000,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | (25,000) | 49,000 | 34,000 | 13,000 |
|
Earnings Before Interest And Taxes | 1,478,000 | 1,673,000 | 1,357,000 | 1,013,000 |
|
Interest Expense | 34,000 | 32,000 | (68,000) | 130,000 |
|
Income Before Tax | 1,444,000 | 1,641,000 | 1,425,000 | 883,000 |
|
Income Tax Expense | 57,000 | 547,000 | 483,000 | 295,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 1,387,000 | 1,094,000 | 942,000 | 588,000 | |
|
Non-recurring Events |
|
Discontinued Operations | 6,000 | 4,000 | (1,000) | (2,000) |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
1,393,000
|
1,098,000
|
941,000
|
586,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
1,393,000
|
1,098,000
|
941,000
|
586,000
|
|